AI optimizes existing knowledge but doesn't expedite drug approval or reduce costs compared to traditional methods. Explore ...

Integrating AI tools into drug discovery introduces a mix of opportunities and challenges for startups and large pharmaceutical companies.

CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, today announced it has entered into a strategic partnership with ...

The Greater Bay Area (GBA) has potential as a hub for biomedical innovation, thanks in part to Hong Kong’s basic research ...

Enhanc3D Genomics (‘Enhanced’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug ...

Medicines Discovery Catapult (MDC), the national Life Sciences service dedicated to driving productivity and impact in drug R ...

A groundbreaking study led by Nobel Laureate David Baker and Timothy Patrick Jenkins introduces innovative, computationally ...

The AI-designed proteins neutralized lethal 3FTx toxins found in snake venom, which are often the reason that traditional antivenoms fail.

At the JP Morgan Healthcare Conference 2025, Charles River CEO blamed low client spending, loss of a contract and other reasons for lower 2025 projections.

Faro Health Inc., the leading AI-powered platform for data-driven clinical protocol design, today announced it has partnered with Recursion (NASDAQ: RXRX) to accelerate and optimize clinical protocol ...

Geewananda Gunawardana, Ph.D. In his excellent article on “Poor-quality and counterfeit medicines and unnecessary drugs” (The Island 06 January, 2025), Professor Saman Gunatilake wrote, “However, in ...

Welcome to the latest edition of “Quantum Leap” where The Fly decodes news and activity in the quantum computing space. Stay Ahead of the ...